All In MedTech

Device Trial Radar · NCT05088265

Bigfoot Unity Real World Study

Prospective Real World Data Collection for the Bigfoot Unity Diabetes Management System

Last checked: Nov 20, 2026Latest source record: Feb 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

500

Planned (sponsor's estimate)

Start

Oct 26, 2021

Primary completion

Nov 2024

Study completion Feb 2025

Sponsor

Lead sponsor
Bigfoot Biomedical Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Jaeb Center for Health Research
First posted
Oct 21, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is observational, designed to collect real world use and safety data for those using the Bigfoot Unity Diabetes Management System for 12 months. Participants will be those with a prescription to use the Bigfoot Unity System. Medical practices prescribing Bigfoot Unity and Sponsor representatives will provide information about the study to current users and individuals considering initiation of the Bigfoot Unity System. During the course of the study, participants will be asked to use the Bigfoot Unity System in accordance with the prescription provided by their healthcare professional (HCP).

Conditions

  • Type 1 or Type 2 Diabetes

Interventions

  • Bigfoot Unity Diabetes Management SystemDevice

    The Bigfoot Unity System is a wirelessly connected set of hardware and software that is intended for use by people with diabetes mellitus who use disposable insulin pens for self-injection of insulin. Bigfoot Unity consists of the Abbott FreeStyle Libre 2 Sensor, two durable insulin pen caps (one each for specific rapid-acting and long-acting insulin pens) and an iOS-specific mobile App.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in HbA1cTime frame: 3 months

35 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bigfoot Biomedical Inc.

    Milpitas, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.